SELLAS Life Sciences Group, Inc. News - SLS

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$47.31
CHART Trader
Monthly Subscription
for only
$27.87
SMALL CAP PRO
Monthly Subscription
for only
$44.59
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN
SELLAS Life Sciences Group, Inc. SLS NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.02 -1.82% 1.08 1.16 1.06 1.11 1.1 18:00:00
more quote information »

Recent News

Date Time Source Heading
9/13/201808:30GLOBESELLAS Receives Orphan Medicinal Product Designation..
8/15/201808:00GLOBESELLAS Life Sciences Provides Business Update and Reports..
8/14/201816:40EDGARQuarterly Report (10-q)
8/06/201817:11EDGARCurrent Report Filing (8-k)
7/27/201806:18EDGARNotice of Effectiveness (effect)
7/26/201816:55EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
7/26/201816:47EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
7/23/201817:25EDGARStatement of Ownership (sc 13g)
7/23/201817:09EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
7/23/201816:29EDGARCurrent Report Filing (8-k)
7/23/201816:14EDGARStatement of Ownership (sc 13g)
7/23/201808:40GLOBESELLAS To Present Data from Phase 2b Trial of NeuVax +..
7/20/201808:30GLOBESELLAS Receives Fast Track Designation from FDA for..
7/19/201817:33EDGARSecurities Registration Statement (simplified Form) (s-3)
7/18/201817:03EDGARCurrent Report Filing (8-k)
7/18/201813:51EDGARStatement of Ownership (sc 13g)
7/16/201811:23GLOBESELLAS Life Sciences Announces Closing of $24.2 Million..
7/13/201817:26EDGARProspectus Filed Pursuant to Rule 424(b)(4) (424b4)
7/12/201808:45GLOBESELLAS Life Sciences Announces Pricing of Upsized $24.2..
7/12/201806:02EDGARPost-effective Amendment Filed Solely to Add Exhibits to a..
7/12/201806:01EDGARNotice of Effectiveness (effect)
7/11/201806:39EDGARSecurities Registration Statement (s-1/a)
6/26/201807:46GLOBESELLAS Life Sciences Announces Proposed Public Offering of..
6/26/201807:24EDGARSecurities Registration Statement (s-1/a)
6/13/201818:36EDGARStatement of Changes in Beneficial Ownership (4)
6/13/201818:35EDGARStatement of Changes in Beneficial Ownership (4)
6/13/201818:34EDGARStatement of Changes in Beneficial Ownership (4)
6/13/201818:34EDGARStatement of Changes in Beneficial Ownership (4)
6/13/201818:32EDGARStatement of Changes in Beneficial Ownership (4)
6/13/201818:30EDGARStatement of Changes in Beneficial Ownership (4)
6/13/201816:52EDGARCurrent Report Filing (8-k)
6/04/201808:45GLOBESELLAS Life Sciences Presents Interim Phase 1 Clinical Data..
6/01/201816:12EDGARCurrent Report Filing (8-k)
6/01/201808:45GLOBESELLAS Life Sciences Provides Clinical Update on Phase 2b..
5/24/201816:32EDGARCurrent Report Filing (8-k)
5/24/201806:06EDGAR(DEL AM)
5/23/201816:21EDGARSecurities Registration Statement (s-1)
5/22/201806:01EDGARNotice of Effectiveness (effect)
5/21/201817:21EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
5/17/201808:45GLOBESELLAS Life Sciences to Present Phase 1/2 Clinical Data of..
5/16/201816:14EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/15/201817:26EDGARQuarterly Report (10-q)
5/10/201817:32EDGARSecurities Registration Statement (simplified Form) (s-3)
5/09/201816:30GLOBESELLAS Life Sciences Receives FDA Orphan Drug Designation..
5/02/201817:43EDGARCurrent Report Filing (8-k)
5/02/201808:45GLOBESELLAS Life Sciences Completes Second Tranche of $10,700,000..
5/01/201810:37EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/01/201810:19EDGARProxy Statement (definitive) (def 14a)
4/26/201817:46EDGARCurrent Report Filing (8-k)
4/24/201817:03EDGARCurrent Report Filing (8-k)
See more news about this stock »
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20180923 06:23:25